Evaluation of hybrid 68Ga-PSMA ligand PET/CT in 248 patients with biochemical recurrence after radical prostatectomy

M Eiber, T Maurer, M Souvatzoglou… - Journal of nuclear …, 2015 - Soc Nuclear Med
The expression of prostate-specific membrane antigen (PSMA) is increased in prostate cancer.
Recently, 68 Ga-PSMA (Glu-NH-CO-NH-Lys-(Ahx)-[ 68 Ga(HBED-CC)]) was developed …

Diagnostic Efficacy of 68Gallium-PSMA Positron Emission Tomography Compared to Conventional Imaging for Lymph Node Staging of 130 Consecutive Patients …

…, H Kübler, AJ Beer, M Schwaiger, M Eiber - The Journal of …, 2016 - auajournals.org
Purpose : Current standard imaging techniques are insufficient to reliably detect lymph
node metastases in prostate cancer. Recently ligands of PSMA (prostate specific membrane …

68Ga-PSMA PET/CT: Joint EANM and SNMMI procedure guideline for prostate cancer imaging: version 1.0

WP Fendler, M Eiber, M Beheshti, J Bomanji… - European journal of …, 2017 - Springer
The aim of this guideline is to provide standards for the recommendation, performance,
interpretation and reporting of 68 Ga-PSMA PET/CT for prostate cancer imaging. These …

Assessment of 68Ga-PSMA-11 PET accuracy in localizing recurrent prostate cancer: a prospective single-arm clinical trial

WP Fendler, J Calais, M Eiber, RR Flavell… - JAMA …, 2019 - jamanetwork.com
Importance In retrospective studies, 68 Ga-PSMA-11 positron emission tomographic (PET)
imaging improves detection of biochemically recurrent prostate cancer compared with …

First clinical experience with integrated whole-body PET/MR: comparison to PET/CT in patients with oncologic diagnoses

A Drzezga, M Souvatzoglou, M Eiber… - Journal of Nuclear …, 2012 - Soc Nuclear Med
The recently introduced first integrated whole-body PET/MR scanner allows simultaneous
acquisition of PET and MRI data in humans and, thus, may offer new opportunities, particularly …

Systemic Radioligand Therapy with 177Lu Labeled Prostate Specific Membrane Antigen Ligand for Imaging and Therapy in Patients with Metastatic Castration …

…, M Schwaiger, R Tauber, M Eiber - The Journal of …, 2016 - auajournals.org
Purpose : We report our initial clinical experience with β -emitting 177 Lu-PSMA-I&T ( 177
Lu labeled prostate specific membrane antigen ligand for imaging and therapy) for systemic …

Current use of PSMA–PET in prostate cancer management

T Maurer, M Eiber, M Schwaiger… - Nature Reviews …, 2016 - nature.com
Currently, the findings of imaging procedures used for detection or staging of prostate
cancer depend on morphology of lymph nodes or bone metabolism and do not always meet …

Simultaneous 68Ga-PSMA HBED-CC PET/MRI improves the localization of primary prostate cancer

M Eiber, G Weirich, K Holzapfel, M Souvatzoglou… - European urology, 2016 - Elsevier
… Financial disclosures: Matthias Eiber certifies that all conflicts of interest, including specific
Matthias Eiber receives travel sponsoring from Bayer and honoraria from Astellas and …

68Ga-and 177Lu-labeled PSMA I&T: optimization of a PSMA-targeted theranostic concept and first proof-of-concept human studies

…, M Lassmann, I Klette, M Eiber… - Journal of Nuclear …, 2015 - Soc Nuclear Med
On the basis of the high and consistent expression of prostate-specific membrane antigen (PSMA)
in metastatic prostate cancer (PC), the goal of this study was the development, …

Prostate cancer molecular imaging standardized evaluation (PROMISE): proposed miTNM classification for the interpretation of PSMA-ligand PET/CT

M Eiber, K Herrmann, J Calais… - Journal of Nuclear …, 2018 - Soc Nuclear Med
Prostate-specific membrane antigen (PSMA)–ligand PET imaging provides unprecedented
accuracy for whole-body staging of prostate cancer. As PSMA-ligand PET/CT is increasingly …